ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2‐Inhibitors

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|8|2007-2018

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.8, 2015-10, pp. : 2007-2018

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pelitinib (EKB‐569) targets the up‐regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 16, 2015-08 ,pp. : 4089-4106

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transporter genes ABCG2 rs2231142 and ABCB1 rs1128503 polymorphisms and atorvastatin response in Chilean subjects

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 87-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors Enhance Ciprofloxacin-Induced Phototoxicity by Inhibiting ABCG2

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 364-370

Karger

Access to resources Recommend Favorite

EZH2 expression is a prognostic factor in childhood intracranial ependymoma: A Canadian Pediatric Brain Tumor Consortium study

By  

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1499-1507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma

By  

Urologia Internationalis, Vol. 75, Iss. 3, 2005-10 ,pp. : 252-257

Karger

Access to resources Recommend Favorite